Filing Flows › Harvard Apparatus Regenerative Technology (HRGN) › Q4 2024
Harvard Apparatus Regenerative Technology (HRGN) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 31, 2025
Harvard Apparatus Regenerative Technology (HRGN) reported revenue of $258K for the fourth quarter 2024 (Q4 2024), +310% from a year earlier and +337% from the quarter before. Operating margin was -529.1%, net loss $1.3M (520.9% of revenue).
Harvard Apparatus Regenerative Technology, Q4 2024: revenue $258K (+310% year over year), operating margin -529.1%, net loss $1.3M, operating cash flow −$1.1M. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $258K | +337% | +310% |
| Operating profit | −$1.4M | — | — |
| Net earnings | −$1.3M | — | — |
| Operating cash flow | −$1.1M | — | — |
What changed
Revenue was $258K in Q4 2024, up 310% year over year and up 337% from the previous quarter.
Operating costs exceeded revenue by $1.4M, an operating margin of -529.1%. Total costs fell 14% while revenue rose 310%. The quarter ended with a net loss of $1.3M, narrower than the previous quarter's $1.9M loss.
Operating cash flow was −$1.1M. Non-cash charges added back $2K of depreciation and $708K of share-based compensation. Working capital and other items used $491K.
Questions
What was Harvard Apparatus Regenerative Technology's revenue in the fourth quarter 2024?
Harvard Apparatus Regenerative Technology (HRGN) reported revenue of $258K for the fourth quarter 2024 (Q4 2024), +310% from a year earlier and +337% from the quarter before.
Was Harvard Apparatus Regenerative Technology profitable in the fourth quarter 2024?
Operating loss was $1.4M (-529.1% of revenue) and net loss $1.3M.
Source: Harvard Apparatus Regenerative Technology 10-K on SEC EDGAR.